Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Merck & Co., Inc. (MRK) vs Novartis AG (NVS)

Merck & Co., Inc. and Novartis AG are both Drug Manufacturers General companies. Merck & Co., Inc. is the larger, with a market value of $365.4B against $264.3B — 1.4× the size. Novartis AG trades at the lower P/E: 21.8× against 119×. Merck & Co., Inc. grew revenue faster over the last twelve months: 4.64% against 2.73%. Novartis AG has the higher net margin (22.5% vs 4.77%) and the higher return on invested capital (13.1% vs 5.08%). Both pay a dividend; Novartis AG yields more (3.69% vs 2.58%). Across the 23 metrics below, Novartis AG leads on 19 and Merck & Co., Inc. on 4.

Valuation

Metric MRK NVS Drug Manufacturers General median
P/E 119.02 21.84 24.72
P/S 5.52 4.89 3.35
P/B 8.75 6.61 5.00
Price to free cash flow 22.88 18.26 17.68
EV/EBITDA 30.03 14.04 13.91
EV/Sales 6.18 5.58 3.95
Earnings yield 0.84% 4.58% 2.92%
Free cash flow yield 4.37% 5.48% 4.42%

Profitability

Metric MRK NVS Drug Manufacturers General median
Gross margin 72.97% 74.74% 72.77%
Operating margin 10.49% 30.17% 18.90%
Net margin 4.77% 22.50% 8.27%
Free cash flow margin 24.13% 26.77% 17.25%
Return on equity 6.97% 30.37% 6.97%
Return on assets 2.57% 11.27% 2.76%
Return on invested capital 5.08% 13.14% 6.30%

Growth

Metric MRK NVS Drug Manufacturers General median
Revenue growth (TTM) 4.64% 2.73% 6.79%
EPS growth (last fiscal year) 8.01% 21.81% —
Revenue growth, 5-year CAGR 9.38% 2.58% 3.98%
Net income growth, 5-year CAGR 20.90% 11.62% 0.42%

Health

Metric MRK NVS Drug Manufacturers General median
Debt to equity 1.22 1.12 0.63
Current ratio 1.32 0.86 1.32
Net debt to EBITDA 1.15 0.96 1.15

Dividend

Metric MRK NVS Drug Manufacturers General median
Dividend yield 2.58% 3.69% 3.57%
Payout ratio 2.36 0.97 0.53

Size

Metric MRK NVS Drug Manufacturers General median
Market cap 365.36b 264.33b 125.91b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack